Health Screening and Health Promotion part 2 - LEIK Flashcards
Lipid Disorders - total lipid profile
Total lipid profile after a 9-hour (minimum) fast
Lipid Disorders -
The USPSTF recommends the use of low- to moderate-dose statin when all of the
following criteria area met:
- Aged 40 to 74 years
- The patient has one or more CVD risk factors (i.e., dyslipidemia, DM, hypertension, smoking)
- The patient has a calculated 10-year risk of a cardiovascular event of 10% or greater
- Age 76 years and older without history of heart attack or stroke (insufficient evidence)
Lung Cancer (June 2013) Screening
Screening for persons who smoke (30 pack-years) or have quit in the past 15 years
Age 55 to 80 years: Annual screening with low-dose CT (LDCT)
Discontinue screening once person has not smoked for 15 years or develops a health problem that substantially limits life expectancy or the ability or willingness to have curative lung surgery
Prostate Cancer
Screening
Begin at age 50
Prostate Cancer
Screening
Discuss pros / cons of testing via DRE or PSA blood test
Prostate Cancer
Screening
AA or father with prostate cx before age 65, start
discussion at age 45
Ovarian Cancer (September 2012) Screening
Grade D: Routine screening is not recommended.
Ovarian Cancer (September 2012) Screening
Very high-risk women with BRCA1/BRCA2 mutations: Refer to specialists.
Ovarian Cancer (September 2012) Screening
If ovarian cancer screening is done, transvaginal ultrasound with serum cancer antigen (CA-125)
is ordered.
Ovarian Cancer (September 2012) Screening
The screening starts at age 30 years (or 5–10 years before earliest age of first diagnosis of ovarian cancer in family).
Ovarian Cancer (September 2012) Screening
• Some experts recommend bilateral salpingo-oophorectomy (BSO) between age 35 to 40 years (after childbearing is complete).
Ovarian Cancer (September 2012) Screening
BSO has a significant effect in reducing
ovarian cancer risk in at-risk women.
Ovarian Cancer (September 2012) Screening
High-risk women: Refer for genetic counseling.
Ovarian Cancer (September 2012) Screening
Look for family history of having two or more first- to second-degree relatives with a history of ovarian cancer or a combination of ovarian cancer;
women of Ashkenazi Jewish ethnicity with first-degree
relative (or second-degree relatives on the same side of the family) with breast or ovarian cancer.
Ovarian Cancer (September 2012) Screening - TVUS (transvaginal ultrasound)
TVUS (transvaginal ultrasound) is a test that uses sound waves to look at the uterus, fallopian tubes, and ovaries by putting an ultrasound wand into the vagina. It can help find a mass (tumor) in the ovary, but it can’t actually tell if a mass is cancer or benign. When it is used for screening, most of the masses found are not cancer.
Ovarian Cancer (September 2012) Screening - CA-125 blood test
The CA-125 blood test measures the amount of a protein called CA-125 in the blood. Many women with ovarian cancer have high levels of CA-125. This test can be useful as a tumor marker to help guide treatment in women known to have ovarian cancer, because a high level often goes down if treatment is working. But checking CA-125 levels has not been found to be as useful as a screening test for ovarian cancer. The problem with using this test for ovarian cancer screening is that high levels of CA-125 is more often caused by common conditions such as endometriosis and pelvic inflammatory disease. Also, not everyone who has ovarian cancer has a high CA-125 level. When someone who is not known to have ovarian cancer has an abnormal CA-125 level, the doctor might repeat the test (to make sure the result is correct) and may consider ordering a transvaginal ultrasound test.
Skin Cancer Counseling
Recommended for children, adolescents, and young adults (ages 10–24 years) with fair skin
Skin Cancer Counseling
Education includes avoidance of sunlight from 10 a.m. to 4 p.m., use of SPF 15 or higher sunblock, protective clothing, wide-brim hats